New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

PSCHvsBBPETF Comparison

ETF 1
PSCH

Invesco S&P SmallCap Health Care ETF

This fund is part of
US Health Care
-2%
Full PSCH fund page
VS
ETF 2
BBP

Virtus LifeSci Biotech Products ETF

This fund is part of
Tomorrow's Treatments
-2.17%
Full BBP fund page

Invesco S&P SmallCap Health Care ETF (PSCH) belongs to the US Health Care segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 3 sector exposures: and Health Care. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.79% for BBP. PSCH is down -9.57% year-to-date (YTD) with -$14M in YTD flows. BBP performs better with 5.62% YTD performance, and +$4M in YTD flows. Run a side-by-side ETF comparison of PSCH and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PSCH vs BBP performance and flow charts

Performance

-8.0-6.0-4.0-2.00.02.04.06.0%Feb 11Feb 19Feb 26Mar 5Mar 12

Cumulative Flows

-10 M-5 M0 M5 MFeb 11Feb 19Feb 26Mar 5Mar 12

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/12/2026
1M3MYTD1Y3Y5Y
Perf.
PSCH
BBP
-4.98%+2.73%
-13.47%+7.35%
-9.57%+5.62%
-4.84%+41.19%
-5.55%+72.79%
-37.27%+54.18%
Flows
PSCH
BBP
-$12M+$4M
-$15M+$16M
-$14M+$4M
-$33M+$19M
-$168M+$19M
-$230M+$9M
Volatility and drawdown
3M1Y3Y5Y
Volatility
PSCH
BBP
+19.05%+24.64%
+23.19%+25.49%
+21.52%+23.37%
+22.79%+26.10%
Max drawdown
PSCH
BBP
-13.93%-7.42%
-13.93%-17.97%
-23.50%-25.54%
-47.23%-38.24%
Max drawdown duration
PSCH
BBP
80d32d
80d106d
449d292d
1719d915d
Trading data

Create an account to view trading data

Join for free
PSCH
BBP
Last sale
3/12/2026 at 1:30 PM
$39.81
$81.25
Previous close
03/12/2026
$41.15
$81.68
Consolidated volume
03/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PSCH
BBP
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
PSCH
BBP
Last price
$39.81
$81.25
1D performance
-3.26%
-0.53%
AuM$120.40 M$50.55 M
E/R0.29%0.79%
Characteristics
PSCH
BBP
Management strategyPassivePassive
ProviderInvescoVIRTUS Investment Partners
BenchmarkS&P SmallCap 600 Capped Health Care IndexLifeSci Biotechnology Products Index
N° of holdings7158
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateApril 7, 2010December 16, 2014
ESGNoNo
Advertisement
Exposure

Countries

PSCH
USA
95.98%
Other
4.02%
BBP
USA
90.82%
Other
9.18%

Sectors

PSCH
Health Care
91.17%
Other
8.83%
BBP
Health Care
88.88%
Other
11.12%
Advertisement

Diversification

PSCH

Total weight of top 15 holdings out of 15

43.5%
BBP

Total weight of top 15 holdings out of 15

30.11%

Top 15 holdings

Data as of January 31, 2026
PSCH
ARROWHEAD PHARMACEUTICALS INC
4.98%
KRYSTAL BIOTECH INC
3.88%
GLAUKOS
3.85%
PTC THERAPEUTI/D
3.30%
ALKERMES
2.95%
RADNET
2.78%
MERIT MEDICAL SYSTEMS
2.64%
PROTAGONIST THERAPEUTICS INC
2.61%
TRANSMEDICS GROUP
2.57%
TELEFLEX
2.48%
US10950A1060
2.46%
CORCEPT THERAPEUTICS
2.31%
US45579U1097
2.26%
TG THERAPEUTICS
2.25%
ADMA BIOLOGICS INC
2.18%
BBP
DAY ONE BIOPHARMACEUTICALS
2.39%
DYNAVAX TECHNOLOGIES
2.39%
AMICUS THERAPEUTICS
2.25%
IOVANCE BIOTHERAPEUTICS INC
2.18%
ARDELYX
2.09%
AXSOME THERA CMN STK
2.07%
BIONTECH SE ADR
2.07%
GILEAD SCIENCES
1.90%
KRYSTAL BIOTECH INC
1.89%
HALOZYME THERAPEUTICS
1.86%
US52635N1037
1.85%
AMGEN-T
1.83%
THERAVANCE BIOPHARMA
1.80%
INCYTE
1.78%
EXELIXIS
1.77%
Frequently asked questions about PSCH and BBP

How have the PSCH and BBP ETFs performed in 2026?

As of March 12, 2026, PSCH is down -9.57% year-to-date (YTD), while BBP has returned 5.62%. That puts BBP better performer ahead so far this year.

Which ETF is attracting more investor money: PSCH or BBP?

Year-to-date, the PSCH ETF saw -$14M in flows, compared to +$4M for BBP.

Which ETF is more volatile: PSCH or BBP?

Over the past year, PSCH had a volatility of 23.19%, while BBP experienced 25.49%.

Which ETF is bigger: PSCH or BBP?

As of March 12, 2026, PSCH holds $120.40 M in assets under management (AUM), while BBP manages $50.55 M.

What sectors do the PSCH and BBP ETFs invest in?

PSCH leans toward sectors like Health Care. Meanwhile, BBP focuses on Health Care.

What are the top holdings of the PSCH ETF and BBP ETF?

PSCH top holdings include ARROWHEAD PHARMACEUTICALS INC, KRYSTAL BIOTECH INC and GLAUKOS. BBP holds in its top three: DAY ONE BIOPHARMACEUTICALS, DYNAVAX TECHNOLOGIES and AMICUS THERAPEUTICS.

Which ETF is more diversified: PSCH or BBP?

PSCH holds 75 securities with 43.5% of its assets in the top 15. BBP has 63 securities and a top 15 weight of 30.11%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up